Key Points
- Claritev SVP Nutter Carol bought 875 shares on June 9 at an average price of $28.41, spending about $24,859. After the purchase, she directly owned 46,941 shares valued at roughly $1.33 million.
- The transaction increased her ownership by 1.90% and was disclosed in an SEC filing.
- Claritev’s stock recently traded at $29.55, with institutional investors owning 87.15% of the company; analysts currently have a consensus Moderate Buy rating with an average price target of $33.67.
Claritev (NYSE:CTEV - Get Free Report) SVP Nutter Carol acquired 875 shares of Claritev stock in a transaction on Tuesday, June 9th. The shares were purchased at an average price of $28.41 per share, for a total transaction of $24,858.75. Following the completion of the purchase, the senior vice president directly owned 46,941 shares of the company's stock, valued at approximately $1,333,593.81. This represents a 1.90% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link.
Claritev Stock Performance
Shares of CTEV stock opened at $29.55 on Thursday. The stock's fifty day moving average price is $22.36 and its two-hundred day moving average price is $26.74. The company has a market cap of $503.83 million, a PE ratio of -1.71 and a beta of 0.77. Claritev has a fifty-two week low of $11.50 and a fifty-two week high of $74.07.
Institutional Investors Weigh In On Claritev
Several hedge funds have recently modified their holdings of the company. H&F Corporate Investors VIII Ltd. acquired a new stake in shares of Claritev during the 3rd quarter valued at $285,988,000. Arini Captial Management Ltd acquired a new stake in shares of Claritev during the 4th quarter valued at $64,291,000. Public Investment Fund acquired a new stake in shares of Claritev during the 3rd quarter valued at $68,009,000. Beach Point Capital Management LP boosted its holdings in shares of Claritev by 77.4% during the 4th quarter. Beach Point Capital Management LP now owns 755,002 shares of the company's stock valued at $32,276,000 after acquiring an additional 329,424 shares in the last quarter. Finally, Vanguard Group Inc. acquired a new stake in shares of Claritev during the 3rd quarter valued at $27,483,000. Institutional investors and hedge funds own 87.15% of the company's stock.
Wall Street Analyst Weigh In
A number of equities research analysts have weighed in on CTEV shares. Wall Street Zen downgraded Claritev from a "hold" rating to a "sell" rating in a report on Saturday, April 25th. Canaccord Genuity Group started coverage on Claritev in a report on Friday, May 29th. They issued a "buy" rating and a $32.00 target price on the stock. Guggenheim reaffirmed a "buy" rating on shares of Claritev in a report on Tuesday, February 24th. UBS Group restated a "buy" rating on shares of Claritev in a research note on Tuesday, February 24th. Finally, Wells Fargo & Company reduced their price target on shares of Claritev from $30.00 to $22.00 and set an "equal weight" rating on the stock in a research note on Thursday, March 19th. Five research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $33.67.
View Our Latest Stock Analysis on CTEV
About Claritev
(
Get Free Report)
Claritev is a healthcare technology, data and insights company focused on improving affordability, transparency and quality. Led by deeply experienced associates, data scientists, and innovators, Claritev provides tech-enabled solutions and services fueled by multiple data sources from over 40 years of claims repricing. Claritev utilizes world-class technology and AI solutions to power a robust enterprise platform that delivers meaningful insights to drive affordability in healthcare, brings price transparency and optimizes networks and benefits design.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
